Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Learn what you need to know about cash back taxes to optimize your financial strategies. Stay ahead in tax planning.
25,545 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Retirees chasing amlp’s 7.9% yield face a tug-of-war between high income and the risk of payout gaps. This deep dive ...
When Berkshire Hathaway named Greg Abel to lead investments, the portfolio made a surprising pivot. This article brea...
When a fund trims Frontier stock, it can signal rebalancing, risk management, or strategic shifts. This article break...
During 13F season, big investors reveal shifts in their portfolios. This piece explains the move, why Microsoft was f...
Crypto fund flows are shifting. While bitcoin, ethereum etfs shed money, hyperliquid funds are drawing fresh buyers i...
A 62-year-old with $1.4 million faces a five-year bridge to Social Security. Experts urge planners to treat this as a...
Paysign stock skyrocketing today has traders buzzing about a rapid move in a healthcare fintech company. This guide b...
A fresh take on dine brands (din) 2025, focusing on Q4 signals, brand momentum, and how investors can position themse...
As planet labs (pl) 2026 nears, investors weigh growth against costs in a fast-evolving space data market. This guide...
As mdxhealth (MDXH) 2025 earnings unfold, investors watch cash burn, pipeline progress, and strategic partnerships. T...
A former Workday executive argues that attitude, authenticity, and relationships—not titles—drive success in an AI er...